Literature DB >> 26961517

10 years of Vertigo Clinic at National Hospital Abuja, Nigeria: what have we learned?

Abiodun D Olusesi1,2, J Abubakar3,4.   

Abstract

The clinician's major role in management of the dizzy patient involves determining what dizziness is vertigo, and what vertigo is of central or peripheral origin. These demand attention to details of history, otolaryngological workup including vestibular assessment, and often use of diagnostic and management algorithms. There is paucity of published reports of the management outcomes of peripheral vestibular diseases from Africa. Two tertiary care otologist-led dedicated vertigo clinics are located in Abuja, Nigeria. A prospective, non-randomized study of patients presenting with features of peripheral vestibular diseases attending the National Hospital Abuja Nigeria (between May 2005 and April 2014) and CSR Otologics Specialist Clinics (May 2010 to April 2014) was carried out. Both institutions adopted the same diagnostic and management protocols. Data extracted from anonymized databases created for this study include age, sex, vertigo duration (acute <12 weeks, chronic >12 weeks), dizziness handicap inventory score at presentation and at subsequent visits, otological and vestibular findings, ice-water caloric testing results, other investigation outcomes, treatments offered and outcomes. 561/575 (97.5 %) of the cases recorded had peripheral vestibular disease. The male-to-female ratio was 290:271. The mean age of the subjects was 44.7 years. Duration of vertigo at presentation was acute in 278 subjects and chronic in 283 subjects. Identifiable clinical diagnostic groups include BPPV (n = 200), Meniere's disease (n = 189), cervicogenic vertigo (n = 35), labyrinthitis (n = 32), Migraine-associated vertigo (MAV) (n = 32), cholesteatoma/perilymph Fistula (n = 10), climacteric vertigo (n = 8) and unclassified vertigo (n = 55). Migraine-associated vertigo recorded the highest DHI score (95 % CI 75 ± 4.3), followed by cholesteatoma/perilymph fistula (95 % CI 72 ± 6.1) and labyrinthitis (95 % CI 62 ± 1.9). Pure tone audiometry (95 % CI 67.3 ± 3.43), followed by thyroid function tests (95 % CI 66.7 ± 23.55) and ice-water caloric testing (95 % CI 59.7 ± 2.69) were investigations with the highest yields. 86.5 % of cases were treated by either vestibular suppressant medications alone (n = 285) and/or particle repositioning maneuver (n = 200) with improvement in vertigo control (95 % CI 63.63 to 74.37 % and 62.59 to 75.41 %, respectively). Peripheral vestibular diseases constitute majority of cases of self-reported vertigo seen in our setting. Migraine-associated vertigo seen in our setting all have peripheral vestibular signs. Dedicated vertigo clinics could significantly improve the diagnostic and treatment yield in a resource-constrained setting like ours. Most cases can be managed using non-operative measures.

Entities:  

Keywords:  Africa; BPPV; Diagnostic outcomes; Meniere’s disease; Migraine-associated vertigo; Peripheral vestibular disease; Treatment outcomes; Vertigo

Mesh:

Year:  2016        PMID: 26961517     DOI: 10.1007/s00405-016-3969-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

1.  Impact of bilaterality and headache on health-related quality of life in Meniere's disease.

Authors:  Jose A Lopez-Escamez; David Viciana; Pablo Garrido-Fernandez
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-06       Impact factor: 1.547

2.  [Diseases of the peripheral vestibular system: contribution of ENT medical diagnostics and therapy].

Authors:  F Pabst; J Machetanz; U Gerk; G Simonis; S Schellong
Journal:  Internist (Berl)       Date:  2015-01       Impact factor: 0.743

3.  Vestibular abnormality in patients with Meniere's disease and migrainous vertigo.

Authors:  Jung Eun Shin; Chang-Hee Kim; Hong Ju Park
Journal:  Acta Otolaryngol       Date:  2012-11-13       Impact factor: 1.494

4.  Vestibular disorders among adults in a tertiary hospital in Lagos, Nigeria.

Authors:  O A Somefun; O S Giwa; B A Bamgboye; I Irene Okeke-Igbokwe; A A Abdul Azeez
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-13       Impact factor: 2.503

5.  Sensitivity and specificity of mastoid vibration test in detection of effects of vestibular neuritis.

Authors:  D Nuti; M Mandalà
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-10       Impact factor: 2.124

6.  Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.

Authors:  A D Olusesi; S B Hassan; Y Oyeyipo; U C Ukwuije; O Oyeniran
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-26       Impact factor: 2.503

7.  Evaluation of paraclinical tests in the diagnosis of cervicogenic dizziness.

Authors:  Bénédicte L'Heureux-Lebeau; Alain Godbout; Djamal Berbiche; Issam Saliba
Journal:  Otol Neurotol       Date:  2014-12       Impact factor: 2.311

8.  [Migraine-associated vertigo with hearing loss and recurrent vertigo attack].

Authors:  Fumiyuki Goto; Tomoko Tsutsumi; Kaoru Ogawa
Journal:  Nihon Jibiinkoka Gakkai Kaiho       Date:  2013-05

Review 9.  Metabolic disorders of the vestibular system.

Authors:  L P Rybak
Journal:  Otolaryngol Head Neck Surg       Date:  1995-01       Impact factor: 3.497

10.  Unilateral peripheral vestibular disorders in the emergency room of the ENT Department of Cluj-Napoca, Romania.

Authors:  Maria Petri; Magdalena Chirila; Sorana Bolboaca; Marcel Cosgarea
Journal:  Clujul Med       Date:  2015-04-15
View more
  1 in total

1.  Combination of Two Manipulative Techniques for the Treatment of Cervicogenic Dizziness: A Randomized Controlled Trial.

Authors:  Andoni Carrasco-Uribarren; Pilar Pardos-Aguilella; Silvia Pérez-Guillén; Carlos López-de-Celis; Jacobo Rodríguez-Sanz; Sara Cabanillas-Barea
Journal:  Life (Basel)       Date:  2022-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.